Promising Brain Stimulation Tech to Combat Depression, Secures €5M Funding

Adam Carter

A Finnish startup company called Sooma has developed a portable brain stimulation device for treating depression. This device uses a treatment called Transcranial Direct Current Stimulation (tDCS). tDCS provides an alternative for people who may not respond well to medications or who have limited access to psychotherapy.

What’s Happening & Why This Matters

tDCS uses a low electrical current to stimulate specific parts of the brain. The mild electrical currents administered through the cap are said to influence the activity of specific brain cells responsible for releasing neurotransmitters related to mood. Recent research has shown that tDCS is linked to increased grey matter in areas of the brain associated with loss of grey matter from depression.

Transcranial Direct Current Stimulation 101: What is tDCS? | by Caputron |  Medium
tDCS explained. IMAGE: Medium/Busines Insider

The device is to be used at home but requires a prescription from a doctor. The treatment may be used on its own or in combination with other therapies. Doctors can monitor patients’ progress and adjust treatments through a digital platform.

Sooma’s device is currently seeking FDA approval in the United States. If approved, it could help bridge the mental health gap by providing a more effective treatment for depression. Sooma has also received European Medical Device Regulation certification, making it the first tDCS device manufacturer to do so.

t/f Summary: What’s Next

The company recently secured €5 million in funding to further develop its product and expand into new and existing markets. This funding will support fast-tracking the FDA certification process, ultimately making the treatment more accessible to patients worldwide.

Sooma’s approach to treating depression offers hope to the underserved or those having limited access to traditional treatment methods. The recent funding and device designations are significant steps toward making this treatment widely available.

Share This Article
Avatar photo
By Adam Carter “TF Enthusiast”
Adam Carter is a staff writer for TechFyle's TF Sources. He's crafted as a tech enthusiast with a background in engineering and journalism, blending technical know-how with a flair for communication. Adam holds a degree in Electrical Engineering and has worked in various tech startups, giving him first-hand experience with the latest gadgets and technologies. Transitioning into tech journalism, he developed a knack for breaking down complex tech concepts into understandable insights for a broader audience.
Leave a comment